| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 1,803 | 8,536 | 6,173 | | Selling General and Administrative | 2,610 | 3,608 | 3,827 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (4,413) | (12,144) | (10,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 209 | 112 | 307 | | Earnings Before Interest And Taxes | (4,204) | (12,032) | (9,693) | | Interest Expense | 65 | 0 | 2 | | Income Before Tax | (4,269) | (12,032) | (9,695) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,269) | (12,032) | (9,695) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (4,269) | (12,032) | (9,695) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,269) | ($12,032) | ($9,695) |
|
1.00% Nasdaq 
Income Statement
